Open original FDA record ↗Recall record
- FDA identifier
- Z-0809-2022
- Company in FDA record
- Biomet, Inc.
- FDA record creation date
- Mar 18, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Packaging of various implants may not have sufficient adhesion on all sides, leading to loss of sterile barrier integrity. Use of product poses risk of infection, leading to surgical intervention, and/or extension of surgery to find another part.
Source facts
- Action
- A recall notification was sent via courier 24 Feb 2022 to distributors, surgeons, and hospital risk managers. Customers advised to locate and quarantine product, return to Biomet and identify any further customers receiving product. Recalled product is identified using specific lot and item numbers. Additionally, surgeons and hospital risk managers are to follow any specified patient monitoring instructions and return the Certificate of Acknowledgement to Zimmer Biomet. If you have further questions or concerns, please call customer service at 574-371-3071 or send questions via email to CorporateQuality.PostMarket@zimmerbiomet.com
- Initiated
- 2022-02-14
- Root cause
- Under Investigation by firm
- Terminated
- 2024-09-30
- Distribution
- Worldwide: US (28 States AL, AZ, CA, CO, CT, FL, GA, ID, IL, IN, KS, KY, LA, MD, MI, MS, NC, NE, NM, NY, OH, OK, OR, SC, TX, UT, WA, WY), Australia, Japan, and Netherlands
- Recall number
- Z-0809-2022
- Recall status
- Terminated
- CDRH record ID
- 192267
- FDA record created
- 2022-03-18
- Recall event number
- 89701